-
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) Guide
2026-09-16
Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a controlled perturbagen in adipocyte–sympathetic neuron–cardiomyocyte models, rather than assuming an unverified direct target. This workflow combines compartment-specific dosing, electrophysiology, conditioned-media transfer, and mechanism-oriented controls to improve interpretation of adipose–neural arrhythmia experiments.
-
BMS-345541 Hydrochloride: A Signaling Assay Guide
2026-09-16
BMS-345541 hydrochloride is a selective IKK inhibitor for dissecting NF-κB signaling, inflammatory transcription, and cell-death outcomes. This guide connects IKK perturbation with RIPK1 biology to improve assay design in inflammation research, T-ALL, and cancer biology.
-
Five-Element Nanoparticles for Stable Lung mRNA Delivery
2026-09-15
Cao and colleagues developed five-element nanoparticles (FNPs) that combine helper poly(β-amino ester) polymers with DOTAP to improve lung-directed mRNA delivery and formulation stability. Their results link polymer structure, nanoparticle interactions, protein-corona biology, and lyophilization to a platform that remained stable at 4 °C for at least 6 months after drying.
-
Ceftazidime in CREC Resistance Research
2026-09-15
Ceftazidime is a third-generation cephalosporin whose value in Gram-negative bacterial infection research extends beyond susceptibility testing. This article presents an assay-centered framework linking phenotype, carbapenemase genetics, plasmid mobility, and reproducible compound handling.
-
WST-8 Glucose Uptake Assay Kit: Practical Workflows
2026-09-14
Build a non-radioactive glucose uptake assay around 2-deoxyglucose metabolism, with practical controls for cell density, reagent timing, and treatment-related interference. The workflow also shows how glucose uptake can serve as a functional metabolic endpoint after ion-optimized cell-penetrating peptide and nucleic acid delivery.
-
SM-164 Workflow for TNFα-Dependent Apoptosis
2026-09-14
SM-164 is a bivalent Smac mimetic for mapping IAP degradation, TNFα signaling, and caspase activation in tumor-cell models. This practical workflow combines rapid cIAP-1/2 loss with orthogonal apoptosis and transcriptional assays to distinguish direct death signaling from nonspecific cytotoxicity.
-
Glabridin–Gold(I) Complex Rewires Antitumor Immunity
2026-09-13
The reference study introduces glabridin–gold(I) complex 6d as a dual-action immunomodulatory agent targeting thioredoxin reductase and MAPK signaling. In liver cancer models, 6d was reported to enhance dendritic-cell maturation, reduce immunosuppressive immune populations, suppress PD-L1, and promote granzyme B production, providing a mechanistic rationale for combination immunotherapy research.
-
ABT-263: From Apoptosis Tool to Strategy
2026-09-12
ABT-263 (Navitoclax) is more than a broad Bcl-2 family inhibitor: it is a way to test whether treatment-surviving cancer cells remain apoptosis-competent. This article connects mitochondrial priming, therapy-induced senescence, biomarker selection, and translational assay design for oncology researchers.
-
Genistein Workflows for Mechanotransduction Studies
2026-09-11
Genistein provides a tunable way to interrogate growth-factor kinase signaling alongside mechanically induced autophagy. This workflow separates pathway modulation, cytotoxicity, and cytoskeleton-dependent stress responses so oncology and mechanobiology assays are easier to interpret.
-
HyperScribe™ Poly (A) Tailing Kit Guide
2026-09-11
The HyperScribe™ Poly (A) Tailing Kit uses E. coli Poly (A) Polymerase to add a product-specified poly(A) tail of at least 150 bases to compatible in vitro-transcribed RNA. This RNA polyadenylation step supports mRNA stability enhancement and translation efficiency improvement in research workflows such as transfection experiments and micro-injection.
-
β-Amanitin: From Transcription to Toxin Detection
2026-09-10
Explore how β-Amanitin connects RNA polymerase II biology with modern amatoxin detection. This evidence-led guide explains assay selection, experimental controls, handling, and the practical significance of computational hapten design.
-
N1-Methylpseudo-UTP for RNA Assay Design
2026-09-10
N1-Methyl-Pseudouridine-5'-Triphosphate enables controlled studies of RNA synthesis, folding, stability, and translation. This guide connects nucleotide chemistry with mRNA vaccine development while translating recent lipid nanoparticle findings into practical assay decisions.
-
Bortezomib (PS-341): Practical Assay Guide
2026-09-09
This guide explains how to use Bortezomib (PS-341), SKU A2614, as a reversible 20S proteasome inhibitor in cell-based viability, growth, and apoptosis workflows. It is intended for controlled research assays and assay development, not as a substitute for a validated clinical, animal, or disease-specific dosing protocol.
-
Ultrasound Nanoparticles for Lung Cancer Therapy
2026-09-09
The reference study develops M@DRSZ, a pH-sensitive, A549-membrane-coated ZIF-8 nanoparticle that combines doxorubicin delivery, nitric oxide generation, ultrasound-triggered redox chemistry, and immune modulation. Its results support a multimodal strategy in which locally generated peroxynitrite contributes to mitochondrial and lysosomal injury, apoptosis, tumor suppression, and improved antitumor immune activity.
-
ABT-263 (Navitoclax): From Mechanism to Translation
2026-09-08
A translational framework for using ABT-263 (Navitoclax) to connect Bcl-2 family dependency, mitochondrial priming, apoptosis assays, and cancer-model strategy.